Filed: 2/13/2026ACC: 0000935836-26-000090
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 64 equity positions with a total reported market value of $136.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
64
Positions
$136.97M
Total AUM (reported)
78.73M
Total Shares
Allocation by class
COM NEW$65.09M47.5%
COM$56.98M41.6%
SPONSORED ADS$5.25M3.8%
ORD$4.06M3.0%
COM SHS$2.97M2.2%
NAMEN AKT$2.62M1.9%
Portfolio Concentration
Top 3$45.44M33.2%
4–10$30.35M22.2%
11–25$35.70M26.1%
Rest$25.49M18.6%
Top 3 weight
33.2%
Top 10 weight
55.3%
Voting Authority Distribution
Total shares with voting rights: 78.73M
Sole
Full voting authority
78.73M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole64
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings64
Rows:
VERASTEM INC
SOLEShares2.73M
TypeSH
Market value$21.09M
15.40%
Sole
2.73M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares740K
TypeSH
Market value$13.50M
9.85%
Sole
740K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares1.63M
TypeSH
Market value$10.85M
7.92%
Sole
1.63M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares135K
TypeSH
Market value$5.71M
4.17%
Sole
135K
Shared
0.00
None
0.00
ZEVRA THERAPEUTICS INC
SOLEShares569.09K
TypeSH
Market value$5.10M
3.72%
Sole
569.09K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares2.35M
TypeSH
Market value$4.81M
3.51%
Sole
2.35M
Shared
0.00
None
0.00
ABEONA THERAPEUTICS INC
SOLEShares909.50K
TypeSH
Market value$4.79M
3.50%
Sole
909.50K
Shared
0.00
None
0.00
INDIVIOR PLC
SOLEShares100K
TypeSH
Market value$3.59M
2.62%
Sole
100K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares389.92K
TypeSH
Market value$3.17M
2.32%
Sole
389.92K
Shared
0.00
None
0.00
KAZIA THERAPEUTICS LTD
SOLEShares460.36K
TypeSH
Market value$3.17M
2.32%
Sole
460.36K
Shared
0.00
None
0.00
XOMA ROYALTY CORPORATION
SOLEShares115K
TypeSH
Market value$3.06M
2.23%
Sole
115K
Shared
0.00
None
0.00
VERRICA PHARMACEUTICALS INC
SOLEShares353.67K
TypeSH
Market value$2.94M
2.15%
Sole
353.67K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares339.90K
TypeSH
Market value$2.78M
2.03%
Sole
339.90K
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares2.35M
TypeSH
Market value$2.78M
2.03%
Sole
2.35M
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$2.67M
1.95%
Sole
100K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares50K
TypeSH
Market value$2.62M
1.91%
Sole
50K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares113.63K
TypeSH
Market value$2.57M
1.87%
Sole
113.63K
Shared
0.00
None
0.00
ALEXANDRIA REAL ESTATE EQ IN
SOLEShares50K
TypeSH
Market value$2.45M
1.79%
Sole
50K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares593.57K
TypeSH
Market value$2.37M
1.73%
Sole
593.57K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares100K
TypeSH
Market value$2.30M
1.68%
Sole
100K
Shared
0.00
None
0.00
AYTU BIOPHARMA INC
SOLEShares813.70K
TypeSH
Market value$2.12M
1.54%
Sole
813.70K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares200K
TypeSH
Market value$1.86M
1.36%
Sole
200K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares220.01K
TypeSH
Market value$1.85M
1.35%
Sole
220.01K
Shared
0.00
None
0.00
SPRUCE BIOSCIENCES INC
SOLEShares19.74K
TypeSH
Market value$1.72M
1.26%
Sole
19.74K
Shared
0.00
None
0.00
HERON THERAPEUTICS INC
SOLEShares1.24M
TypeSH
Market value$1.61M
1.17%
Sole
1.24M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERASTEM INCSOLE | COM NEW | 2.73M | SH | $21.09M 15.40% | 2.73M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 740K | SH | $13.50M 9.85% | 740K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 1.63M | SH | $10.85M 7.92% | 1.63M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 135K | SH | $5.71M 4.17% | 135K | 0.00 | 0.00 |
ZEVRA THERAPEUTICS INCSOLE | COM NEW | 569.09K | SH | $5.10M 3.72% | 569.09K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 2.35M | SH | $4.81M 3.51% | 2.35M | 0.00 | 0.00 |
ABEONA THERAPEUTICS INCSOLE | COM NEW | 909.50K | SH | $4.79M 3.50% | 909.50K | 0.00 | 0.00 |
INDIVIOR PLCSOLE | ORD | 100K | SH | $3.59M 2.62% | 100K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 389.92K | SH | $3.17M 2.32% | 389.92K | 0.00 | 0.00 |
KAZIA THERAPEUTICS LTDSOLE | SPONSORED ADS | 460.36K | SH | $3.17M 2.32% | 460.36K | 0.00 | 0.00 |
XOMA ROYALTY CORPORATIONSOLE | COM NEW | 115K | SH | $3.06M 2.23% | 115K | 0.00 | 0.00 |
VERRICA PHARMACEUTICALS INCSOLE | COM SHS | 353.67K | SH | $2.94M 2.15% | 353.67K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 339.90K | SH | $2.78M 2.03% | 339.90K | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 2.35M | SH | $2.78M 2.03% | 2.35M | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 100K | SH | $2.67M 1.95% | 100K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 50K | SH | $2.62M 1.91% | 50K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 113.63K | SH | $2.57M 1.87% | 113.63K | 0.00 | 0.00 |
ALEXANDRIA REAL ESTATE EQ INSOLE | COM NEW | 50K | SH | $2.45M 1.79% | 50K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 593.57K | SH | $2.37M 1.73% | 593.57K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 100K | SH | $2.30M 1.68% | 100K | 0.00 | 0.00 |
AYTU BIOPHARMA INCSOLE | COM | 813.70K | SH | $2.12M 1.54% | 813.70K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 200K | SH | $1.86M 1.36% | 200K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM NEW | 220.01K | SH | $1.85M 1.35% | 220.01K | 0.00 | 0.00 |
SPRUCE BIOSCIENCES INCSOLE | COM NEW | 19.74K | SH | $1.72M 1.26% | 19.74K | 0.00 | 0.00 |
HERON THERAPEUTICS INCSOLE | COM | 1.24M | SH | $1.61M 1.17% | 1.24M | 0.00 | 0.00 |
Page 1 of 3